For thousands of patients on kidney transplant waiting lists, the difference between a life-saving procedure and years of dialysis often comes down to a narrow window of time and a rigid set of clinical criteria. When a donor kidney is deemed “non-ideal”—perhaps due to the donor’s age or the circumstances of their death—it is frequently declined by transplant centers and left unused, despite having the potential to function in a recipient.
A latest approach to organ preservation is attempting to close this gap. 34 Lives, a Public Benefit Company based in West Lafayette, Indiana, recently announced that it has rescued and repaired for transplant 527 kidneys that would have otherwise been discarded. This milestone includes the 500th rescued organ, which was successfully transplanted on March 29, 2026, by Dr. Jose Figueiro at the Medstar Georgetown Transplant Institute.
The initiative targets a critical failure in the current organ procurement pipeline. According to data from the National Kidney Foundation, more than 101,000 Americans currently need a kidney, while over 123,000 people remain on the national transplant waiting list. Despite the desperate need, the rate of non-use for recovered kidneys in the U.S. Has risen to nearly 30%, with more than 9,000 recovered organs going unused in 2024 alone.
By intervening after a kidney has been declined through standard allocation, the team at 34 Lives uses specialized perfusion technology to stabilize organs that are physiologically viable but clinically “high risk,” effectively expanding the pool of available organs for patients who have otherwise run out of options.
Resetting the Biological Clock
The core of this rescue operation is a process called Normothermic Machine Perfusion (NMP). While traditional preservation often relies on keeping organs cold to slow decay, NMP pumps oxygenated, nutrient-rich blood or a blood-like solution through the kidney at normal body temperature. This process allows the organ to maintain metabolic activity outside the body.
Dr. Jose Figueiro, who has performed transplants for 30 years and has partnered with 34 Lives to transplant over 90 rescued kidneys, describes the technology as a way to “reset the clock.” According to Dr. Figueiro, this method provides the kidney more time outside the body and utilizes diagnostic tools to provide a score that predicts whether the organ is physiologically preserved and suitable for a patient.
This “repair” phase is handled at a centralized Assessment and Repair Center (ARC), launched in April 2024. Located in the Purdue Research Park, the 12,000-square-foot facility operates seven operating rooms and employs over 50 specialists, including biomedical engineers and kidney preservationists. The center specifically utilizes sub-normothermic acellular perfusion (SNAP) to assess and rescue kidneys that have been declined after standard Organ Procurement and Transplantation Network (OPTN) allocation.
Addressing the ‘Hard-to-Place’ Kidney
Not all donor kidneys are created equal. Medical teams categorize certain organs as “hard-to-place” when they carry higher risk profiles. These typically include kidneys from older donors, those with pre-existing risk factors for chronic kidney disease, or donors after circulatory death (DCD).
While a donor’s age or medical history cannot be changed, the factors that lead to an organ being discarded—such as transportation time and preservation technique—are modifiable. The ARC’s functional assessment helps remove the uncertainty that often leads surgeons to decline these organs.
| Metric | Stat/Figure |
|---|---|
| Americans needing a kidney | 101,000+ |
| National transplant waiting list | 123,000+ |
| Recovered kidneys unused (2024) | 9,000+ |
| U.S. Non-use rate of recovered kidneys | ~30% |
| Waitlist patients receiving transplants | 22% |
For the patients affected, the stakes are visceral. Many spend several days a week tethered to dialysis machines, a grueling process that manages kidney failure but does not cure it. CEO Chris Jaynes emphasizes that the goal of the perfusion team is to ensure “no kidney is left behind,” honoring the gift of donation by restoring the futures of those suffering from chronic conditions.
The Path Toward Higher Utilization
The scale of the operation is supported by a diverse funding base, including ARPA-H, the National Kidney Foundation Innovation Fund, Ballad Health, and the Niswonger Foundation. This financial backing allows the company to function as a Public Benefit Corporation, prioritizing the public health outcome of increased organ utilization over traditional profit motives.
The impact of this model extends beyond the 527 kidneys already rescued. By proving that “non-ideal” organs can be safely rehabilitated and successfully transplanted, the program provides a blueprint for reducing the 12,500 annual deaths or critical illnesses experienced by patients who are too sick to receive a transplant while waiting for a “perfect” match.
CEO Kathleen St. Jean noted that the dedication of the staff often requires “all hands on deck,” including holiday weekends, to keep pace with the urgent nature of organ procurement and the narrow windows of viability.
Disclaimer: This article is provided for informational purposes only and does not constitute medical advice. Patients should consult with their healthcare provider or transplant coordinator regarding eligibility and options for organ transplantation.
The organization continues to refine its approach through the OPTIMAL research protocol, which is currently listed on ClinicalTrials.gov (Identifier NCT06263023). This study aims to further optimize donor kidney allocation and preservation services.
We invite readers to share their thoughts or experiences with organ donation and transplantation in the comments below.
